Page last updated: 2024-11-02

pantoprazole and HIV Coinfection

pantoprazole has been researched along with HIV Coinfection in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calcagno, A1
Trentalange, A1
Simiele, M1
Marinaro, L1
Patti, F1
Tettoni, MC1
Trentini, L1
Di Perri, G1
DʼAvolio, A1
Bonora, S1

Other Studies

1 other study available for pantoprazole and HIV Coinfection

ArticleYear
Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole.
    Therapeutic drug monitoring, 2015, Volume: 37, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-HIV Agents; Drug Interactions; HIV Infections; Humans;

2015